Roche Diagnostics Makes List for Fourth Consecutive Year INDIANAPOLIS, Oct. 7 /PRNewswire/ -- InformationWeek ranked Roche Diagnostics as one of the magazine's Top 500 innovative users of technology, an honor bestowed to only a handful of companies in the biotech and pharmaceutical industry. Roche Diagnostics, which ranked...
NEW YORK -- Wall Street Media presents exclusive video of Steven B. Porter, M.D, Ph. D., Chief Medical Officer of Intermune, Inc., (NASDAQ: ITMN), discussing their partnership with Roche. http://www.wsmco.com/show.aspx?1077_Now's_the_time_for_ small-cap_stocks And we're pleased to feature video of Dr. Steven H. Holtzman, Chairman, President and Chief Executive Officer...
In July, Cepheid revised its forecast for 2008 sales from $182-$189 million (see IBO 4/30/80) to $173-$177 million, with product sales expected to be $164-$167 million, due to lower-than-expected noncore clinical partner purchases from BD and Roche and lower Biothreat sales due to a reduction in tests used by the...
Roche has announced that the European Commission has approved a shortened, 16-week course of treatment with Pegasys (peginterferon alfa-2a (40 KD)) plus Copegus ribavirin for certain hepatitis C patients. The four-month treatment course will be for patients with particular strains of chronic hepatitis C (genotype 2 or 3) who...
GENEVA AFP — Swiss pharmaceutical giant Roche announced on Tuesday an investment of 1.2 billion Swiss Francs (743 million dollars) in its production and research units in Switzerland. Of the total, 800 million Swiss francs has been earmarked for the company's main factory in Basel, northern Switzerland. Roche...
DUBLIN AFP — Early indications Friday pointed to a rejection of the Lisbon EU reform treaty by voters in Ireland, an outcome that would pitch the European Union into a new period of crisis. "From what I hear, it is not looking good," Irish Europe Minister Dick Roche, a...
LA JOLLA, Calif. -- The California Healthcare Institute CHI today announced that Daniel O'Day, president and chief executive officer at Roche Molecular Diagnostics RMD, located in Pleasanton, Calif., and Michael Onuscheck, president of the neuromodulation division of Boston Scientific Corporation located in Valencia, Calif., have been elected to its board...
ANS, Belgium AFP — Spaniard Alejandro Valverde held his nerve in a thrilling finish to Liege-Bastogne-Liege to claim his second career victory in cycling's oldest one-day classic here on Sunday. Valverde, runner-up last year to Italian Danilo Di Luca and winner in 2006, capped a tactically astute 261 km...
NUTLEY, N.J., May 9 /PRNewswire/ -- Roche announced today that Sarah Vidal, M.P.H., product director, Rheumatoid Arthritis Marketing at Roche, was honored as a 2008 Rising Star by the Healthcare Businesswomen's Association HBA at the organization's annual awards luncheon on May 8, 2008 in New York City.
BASEL, Switzerland, March 3 /PRNewswire/ -- Physicians from countries worst-affected by the deadly bird flu (H5N1 influenza virus) have reported an increased survival rate in patients treated with the oral antiviral Tamiflu oseltamivir. These data reinforce the World Health Organization WHO advisory...
NEW DELHI AFP — A landmark plea by an Indian drug firm for a "compulsory licence" to sell generic copies of patented drugs to poor countries will continue next month. India's patent office held hearings on the case, the first of its kind in the country that is the...
Founded 30 years ago at the dawn of biotech, Genentech is a legend in an industry where companies yearn to do what it does: to make billions of dollars off of novel drugs while remaining true to innovation and science.Unfortunately, it's also a legend being positioned for a fall....
Shares of networking equipment maker Aruba Networks Inc. of Sunnyvale fell $2.84, or 36.6 percent, to $4.92 Friday, which is the biggest drop since its March initial public offering. The maker of wireless networking equipment said in a statement of preliminary results that second-quarter revenue was as much as $41...
BNET Industries editor, David Hamilton, blogs up the skinny on Roche's attempted acquisition of biotech giant, Genentech. Writes Hamilton: The deal also has a funny smell to it. Roche CEO Severin Schwan claims the merger would save $800 million a year in administrative costs from merging commercial and manufacturing...
Discussions with Roche Continue Under Confidentiality Agreement TUCSON, Ariz. -- Ventana Medical Systems, Inc. (NASDAQ: VMSI), the global leader in tissue-based cancer diagnostics, today responded to Roche's fifth extension of its unsolicited tender offer to acquire all outstanding shares of Ventana for $75.00 in cash per common share. ...
SYDNEY AFP — Australian Lleyton Hewitt mixed serve and volley with his natural counter-punching style to reach the second round of the Sydney International here on Tuesday. The former world number one pressured Frenchman Nicolas Mahut's service to come away with a solid 6-3, 6-4 win in 87 minutes...
Simone Roberts & Tegan Fleming Following a turbulent 12 months for Australian pharmacy in 2006, the profession began the new year in desperate need of some certainty. THE IMPACT of government policies over the past five years on PBS growth rates, plus...
BASEL, Switzerland, November 15 /PRNewswire/ -- - Children Particularly at Risk From Influenza - Severe Season in Australia Claimed 6 Lives Tamiflu oseltamivir significantly reduces illness severity and duration in children one year and older, particularly if given within 24 hours...
BASEL, Switzerland AFP — Swiss pharmaceuticals giant Roche said Friday the European Commission had restored the licence to market the HIV drug Viracept in the European Union withdrawn after a contamination problem. "The European Commission has reinstated the Viracept marketing authorization following its suspension earlier this summer," said a...
